10x Genomics Inc (TXG)
25.38
-0.21
(-0.82%)
USD |
NASDAQ |
May 17, 11:59
10x Genomics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
Date | Value |
---|---|
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.0707 |
September 30, 2019 | 0.0704 |
June 30, 2019 | 1.939 |
March 31, 2019 | |
December 31, 2018 | -0.1349 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
1.939
Maximum
Jun 2019
0.104
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
Teladoc Health Inc | 0.6726 |
American Shared Hospital Services | 0.7773 |
Novo Integrated Sciences Inc | 0.1478 |
Astrana Health Inc | 0.5956 |
Cryo-Cell International Inc | -1.019 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 922.91M |
Total Liabilities (Quarterly) | 204.08M |
Shareholders Equity (Quarterly) | 718.83M |
Current Ratio | 5.216 |